Elaprase and agitation Patient Reports February 13, 2012

Elaprase Side Effects Report #5926754-0
Elaprase side effect was reported by a Physician from CANADA on Oct 02, 2008. Male patient, child 11 years of age, weighting 66.14 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: agitation, cough, dermatitis allergic, discomfort, heart rate increased, infusion related reaction, wheezing. Elaprase dosage: 12 MG, 1X/WEEK, IV DRIP. During the same period patient was treated with VENTOLIN, PULMICORT, FLONASE, SINGULAIR, RANITIDINE, CARBAMAZEPINE, ZINC. Patient recovered.

Elaprase Side Effects Report #6127109-9
Elaprase side effect was reported by a Physician from CANADA on Mar 04, 2009. Male patient, child 11 years of age, weighting 66.14 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: agitation, cough, dermatitis allergic, discomfort, heart rate increased, infusion related reaction, wheezing. Elaprase dosage: 12 MG, 1 X/WEEK, IV DRIP. During the same period patient was treated with VENTOLIN, PULMICORT, FLONASE, SINGULAIR, RANITIDINE, CARBAMAZEPINE, ZINC, VITAMIN C. Patient recovered.

Elaprase Side Effects Report #5603509-8
Elaprase side effect was reported by a Physician from UNITED STATES on Jan 07, 2007. Male patient was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: agitation, pain , somnolence. Elaprase dosage: 0.5 MG/KG, 1X/WEEK, IV DRIP. Patient was hospitalized. Patient recovered.

Elaprase Side Effects Report #5801933-1
Elaprase side effect was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient was diagnosed with mucopolysaccharidosis ii, pain  and was treated with Elaprase. After drug was administered, patient experienced the following side effects: agitation, lethargy, pain , somnolence, therapeutic response decreased. Elaprase dosage: 0.5 MG/KG, 1X/WEEK, IV DRIP. During the same period patient was treated with TORADOL. Patient was hospitalized. Patient recovered.